Classification of sensitizing and irritative potential in a combined in-vitro assay

Toxicology and Applied Pharmacology

Volumn 245, Issue 2, 2010, Pages 211-218

  Wanner, Reinhard ^a   Sonnenburg, Anna ^a   Quatchadze, Maria ^a   Schreiner, Maximilian ^b   Peiser, Matthias ^a   Zuberbier, Torsten ^a   Stahlmann, Ralf ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Bundeswehr Hospital   (Germany)

Author keywords

Contact allergens; Dendritic cells; Dermatology contact dermatitis; Immunologic tests; In vitro tests

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; ALLERGEN; CD86 ANTIGEN; CINNAMALDEHYDE; CINNAMALDEHYDE DERIVATIVE; DODECYL SULFATE SODIUM; ISOEUGENOL; NICKEL; PHENOL; RECOMBINANT CYTOKINE; SALICYLIC ACID; XENOBIOTIC AGENT;

ANTIGEN EXPRESSION; ARTICLE; ASSAY; CELL DIFFERENTIATION; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KERATINOCYTE; LOOSE FIT COCULTURE BASED SENSITIZATION ASSAY; MONOCYTE; SENSITIZATION;

ALLERGENS; ANIMALS; ANTIGENS, CD86; BIOLOGICAL ASSAY; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; DENDRITIC CELLS; DERMATITIS, ALLERGIC CONTACT; HUMANS; IRRITANTS; KERATINOCYTES; MICE; MONOCYTES; RESPIRATORY HYPERSENSITIVITY; XENOBIOTICS;

ANIMALIA; MURINAE;

EID: 77952891626     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2010.02.019     Document Type: Article

References (29)

1. Aeby P., Wyss C., Beck H., Griem P., Scheffler H., Goebel C. Characterization of the sensitizing potential of chemicals by in vitro analysis of dendritic cell activation and skin penetration. J. Invest. Dermatol. 2004, 122:1154-1164.
2. Basketter D., Darlenski R., Fluhr J.W. Skin irritation and sensitization: mechanisms and new approaches for risk assessment. Skin Pharmacol. Physiol. 2008, 21:191-202.
3. Basketter D., Ball N., Cagen S., Carrillo J.C., Certa H., Eigler D., Garcia C., Esch H., Graham C., Haux C., Kreiling R., Mehling A. Application of a weight of evidence approach to assessing discordant sensitisation datasets: implications for REACH. Regul. Toxicol. Pharmacol. 2009, 55:90-96.
4. Casati S., Aeby P., Basketter D.A., Cavani A., Gennari A., Gerberick G.F., Griem P., Hartung T., Kimber I., Lepoittevin J.P., Meade B.J., Pallardy M., Rougier N., Rousset F., Rubinstenn G., Sallusto F., Verheyen G.R., Zuang V. Dendritic cells as a tool for the predictive identification of skin sensitisation hazard. Report and Recommendations of ECVAM Workshop 51. Altern. Lab. Anim. 2005, 33:47-62.
5. Corsini E., Mitjans M., Galbiati V., Lucchi L., Galli C.L., Marinovich M. Use of IL-18 production in a human keratinocyte cell line to discriminate contact sensitizers from irritants and low molecular weight respiratory allergens. Toxicol. In Vitro 2009, 23:789-796.
6. Cotovio J., Grandidier M.-H., Lelièvre D., Roguet R., Tinois-Tessonneaud E., Leclaire J. In vitro acute skin irritancy of chemicals using the validated EPISKIN model in a tiered strategy. AATEX 2008, 14:351-358.
7. Dean J.H., Twerdok L.E., Tice R.R., Sailstad D.M., Hattan D.G., Stokes W.S. ICCVAM evaluation of the murine local lymph node assay. Conclusions and recommendations of an independent scientific peer review panel. Regul. Toxicol. Pharmacol. 2001, 34:258-273.
8. Enk A.H., Katz S.I. Early molecular events in the induction phase of contact sensitivity. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:1398-1402.
9. Gerberick G.F., Ryan C.A., Kern P.S., Dearman R.J., Kimber I., Patlewicz G.Y., Basketter D.A. A chemical dataset for evaluation of alternative approaches to skin-sensitization testing. Contact Dermat. 2004, 50:274-288.
10. Gerberick G.F., Vassallo J.D., Foertsch L.M., Price B.B., Chaney J.G., Lepoittevin J.P. Quantification of chemical peptide reactivity for screening contact allergens: a classification tree model approach. Toxicol. Sci. 2007, 97:417-427.
11. Grabbe S., Steinert M., Mahnke K., Schwartz A., Luger T.A., Schwarz T. Dissection of antigenic and irritative effects of epicutaneously applied haptens in mice. Evidence that not the antigenic component but nonspecific proinflammatory effects of haptens determine the concentration-dependent elicitation of allergic contact dermatitis. J. Clin. Invest. 1996, 98:1158-1164.
12. Hartung T., Rovida C. Chemical regulators have overreached. Nature 2009, 460:1080-1081.
13. Kimber I., Basketter D.A., Gerberick G.F., Dearman R.J. Allergic contact dermatitis. Int. Immunopharmacol. 2002, 2:201-211.
14. McGarry H.F. The murine local lymph node assay: regulatory and potency considerations under REACH. Toxicology 2007, 238:71-89.
15. Natsch A., Emter R., Ellis G. Filling the concept with data: integrating data from different in vitro and in silico assays on skin sensitizers to explore the battery approach for animal-free skin sensitization testing. Toxicol. Sci. 2009, 107:106-121.
16. Nestle F.O., Di Meglio P., Qin J.Z., Nickoloff B.J. Skin immune sentinels in health and disease. Nat. Rev. Immunol. 2009, 9:679-691.
17. Guideline for the testing of chemicals. Guideline no. 429: skin sensitisation: local lymph node assay 2002, OECD, Organisation of Economic Cooperation and Development, Paris.
18. Ohtani T., Mizuashi M., Nakagawa S., Sasaki Y., Fujimura T., Okuyama R., Aiba S. TGF-beta1 dampens the susceptibility of dendritic cells to environmental stimulation, leading to the requirement for danger signals for activation. Immunology 2009, 126:485-499.
19. Palm N.W., Medzhitov R. Immunostimulatory activity of haptenated proteins. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:4782-4787.
20. Pivarcsi A., Istvan N., Kemeny L. Innate immunity in the skin: how keratinocytes fight against pathogens. Curr. Immun. Rev. 2005, 1:29-42.
21. Roberts D.W., Patlewicz G., Kern P.S., Gerberick F., Kimber I., Dearman R.J., Ryan C.A., Basketter D.A., Aptula A.O. Mechanistic applicability domain classification of a local lymph node assay dataset for skin sensitization. Chem. Res. Toxicol. 2007, 20:1019-1030.
22. Schreiner M., Peiser M., Briechle D., Stahlmann R., Zuberbier T., Wanner R. A loose-fit coculture of activated keratinocytes and dendritic cell-related cells for prediction of sensitizing potential. Allergy 2007, 62:1419-1428.
23. Schreiner M., Peiser M., Briechle D., Stahlmann R., Zuberbier T., Wanner R. A new dendritic cell type suitable as sentinel of contact allergens. Toxicology 2008, 249:146-152.
24. Schröder J.M., Reich K., Kabashima K., Liu F.T., Romani N., Metz M., Kerstan A., Lee P.H., Loser K., Schön M.P., Maurer M., Stoitzner P., Beissert S., Tokura Y., Gallo R.L. Who is really in control of skin immunity under physiological circumstances-lymphocytes, dendritic cells or keratinocytes?. Exp. Dermatol. 2006, 15:913-929.
25. Schultz T.W., Rogers K., Aptula A.O. Read-across to rank skin sensitization potential: subcategories for the Michael acceptor domain. Contact Dermat. 2009, 60:21-31.
26. Toebak M.J., Moed H., von Blomberg M.B., Bruynzeel D.P., Gibbs S., Scheper R.J., Rustemeyer T. Intrinsic characteristics of contact and respiratory allergens influence production of polarizing cytokines by dendritic cells. Contact Dermat. 2006, 55:238-245.
27. Van Och F.M., Van Loveren H., Van Wolfswinkel J.C., Machielsen A.J., Vandebriel R.J. Assessment of potency of allergenic activity of low molecular weight compounds based on IL-1alpha and IL-18 production by a murine and human keratinocyte cell line. Toxicology 2005, 210:95-109.
28. Watanabe H., Gaide O., Pétrilli V., Martinon F., Contassot E., Roques S., Kummer J.A., Tschopp J., French L.E. Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity. J. Invest. Dermatol. 2007, 127:1956-1963.
29. White J.M., Kullavanijaya P., Duangdeeden I., Zazzeroni R., Gilmour N.J., Basketter D.A., McFadden J.P. p-Phenylenediamine allergy: the role of Bandrowski's base. Clin. Exp. Allergy 2006, 36:1289-1293.